Tag Archives: PhRMA

BIO Submits Amicus Briefs in Braintree v. Novel, Gilead v. Natco, and Bristol-Myers Squibb v. Teva Pharmaceuticals

scientist-eyedropper

BIO has submitted briefs in three recent cases which could significantly impair drug and biotechnology efforts, urging reconsideration and review from both the Supreme Court and the U.S. Court of Appeals for the Federal Circuit. BIO, in conjunction with PhRMA, submitted an amicus brief to the Supreme Court in Braintree v. Novel, arguing that the majority’s decision creates an unpredictable climate for patent claims. Vacating the prior claim construction precedent which had repeatedly interpreted “a” Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

The Value of Prevention

Copyright sanofi pasteur

Vaccines are widely recognized as one of the most important advances in medical history. Once-devastating diseases like polio, which at its peak claimed the lives of nearly 6,000 Americans each year, have been nearly eradicated. A report issued by the CDC in April estimated that vaccines will prevent 732,000 deaths and 21 million hospitalizations among children born in the US over the past 20 years. Despite this track record of overwhelming success, a recent New Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,